Abstract
Objective: 11-C-methionine positron emission tomography (MET PET) was described as a tool for localization of Cushing adenoma. Due to the low half-life of 11-C(20.38 minute) it is only available in few centers. The use of the more commonly available 18-fluoroethyl-L-tyrosine PET (FET PET) has not been described in Cushing’s disease. The goal of this prospective trial is to analyze the impact of FET PET on localization of Cushing adenoma and on surgical cure rates.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurological Surgery Part A: Central European Neurosurgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
